This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we assess HIV prevalence in African countries?
Providing technical support in developing and implementing community-based HIV impact assessments (PHIAs)
Challenge
The goals of community-based HIV impact assessments (PHIAs) are to define the status of the HIV epidemic in specific President’s Emergency Plan For AIDS Relief (PEPFAR)-supported countries.
The main objectives are to:
- Estimate HIV incidence and/or prevalence of viral load suppression at national and/or subnational levels
- Assess access to and uptake of HIV services at the community level
- Estimate the prevalence of HIV-related risk behaviors
Working with ICAP at Columbia University and the Centers for Disease Control and Prevention, Westat has provided technical support in developing and implementing PHIAs in 15 PEPFAR-supported countries. The 7 most recent were: Lesotho, Zimbabwe, Uganda, Malawi, Eswatini, Mozambique, and Tanzania.
Solution
Westat performs the following tasks:
- Provides statistical expertise in survey sampling and weighting
- Supports all aspects of electronic data collection on tablet computers
- Develops dashboards to track the progress of data collection
- Provides general mapping and global positioning system (GPS) support to facilitate data collection
- Manages the survey data and prepares the final datasets used for analysis
Results
Results of the surveys provide critical information on HIV and help shape national policies and programs to better confront the epidemic.
-
Perspective
Westat Experts Present at AAPOR 2025May 2025
Westat’s public opinion and survey methodology experts are heading to the 80th Annual American Association for Public Opinion Research (AAPOR) Conference, in St. Louis, MO,…
-
Expert Interview
Why Are People Reluctant to Share Health App Data?May 2025
In an age where smart watches track our heart rate, apps detect our sleep patterns, and digital platforms monitor the calories we burn, the potential…
-
Expert Interview
Fine-Tuning LLMs to Improve Adverse Drug Event Detection and ReportingApril 2025
The expedient, accurate detection of the severity of adverse drug events (ADEs) remains a serious challenge. Despite technological advancements, data-driven models often fail to precisely…